Articles Tagged With:
-
Pharmacology Watch: Oral Treatments for Relapsing-remitting MS
In this issue: Two oral medications for relapsing-remitting MS in phase III development; antihypertensives find new uses; Ginkgo biloba does not prevent cognitive decline in elderly; and FDA Actions. -
Clinical Briefs in Primary Care supplement
-
OB/GYN Clinical Alert March 2010 Issue in PDF
-
Bethesda Guidelines for Lynch Syndrome Screening Appear to Improve the Amsterdam Criteria
Lynch Syndrome (LS) is a familial colorectal cancer syndrome, which occurs as a result of autosomal dominant inheritance of DNA mismatch repair genes. -
Critical Care Alert March 2010 Issue in PDF
-
Pharmacology Watch: Oral Treatments for Relapsing-remitting MS
In this issue: Two oral medications for relapsing-remitting MS in phase III development; antihypertensives find new uses; Ginkgo biloba does not prevent cognitive decline in elderly; and FDA Actions. -
Do Antipsychotics Help with ICU Delirium?
Although delirium is a common complication of critical illness associated with considerable morbidity and mortality and haloperidol is widely used for treatment of the problem, there are no controlled studies examining whether this or other medications are effective therapeutic modalities in ICU patients. -
Clinical Briefs in Primary Care supplement
-
Special Feature: Brain Attack
Each year, about 795,000 strokes occur in the United States; 85% of these are acute ischemic strokes. -
Prevention and Treatment Bundle Reduced Incidence of Clostridium difficile Infection
The incidence, severity, and costs of clostridium difficile infection (CDI) are increasing, creating a substantial burden for patients and institutions. Guidelines for prevention of CDI are complex and not consistently followed.